Search

Using Multiple Technologies to Reduce IOP and Drop Burden

I. Paul Singh, MD

Show Description +

I. Paul Singh, MD, demonstrates the use of multiple technologies to reduce a patient's IOP and glaucoma medication burden. He performs iTrack canaloplasty (Nova Eye Medical), iDose implantation (Glaukos), and Dextenza (dexamethasone ophthalmic insert 0.4 mg, Ocular Therapeutix) insertion.

Financial Disclosure: Consultant (Glaukos, Nova Eye Medical)

Posted: 2/17/2026

Keywords:

iTrack

•

iDose TR

•

Dextenza

Up Next

FLACS With Toric and iStent inject

FLACS With Toric and iStent inject

Blake Williamson, MD, MPH, MS

Targeted Placement of iStent Trabecular Micro-Bypass Stent (Glaukos)

Targeted Placement of iStent Trabecular Micro-Bypass Stent (Glaukos)

Eric Rosenberg, MD

Cataract Surgery Combined with Canaloplasty

Cataract Surgery Combined with Canaloplasty

Mahmoud A. Khaimi, MD

Needle Viscocanalostomy

Needle Viscocanalostomy

Eslam Ramadan, MD

Ahmed M4 Placement

Ahmed M4 Placement

Nathan Radcliffe MD

Hydrogel Sealant to Prevent Chamber Shallowing During Combined Phaco and Tube Shunt Insertion

Hydrogel Sealant to Prevent Chamber Shallowing During Combined Phaco and Tube Shunt Insertion

Ian Conner, MD

Supra-Tenons Baerveldt Glaucoma Drainage Device

Supra-Tenons Baerveldt Glaucoma Drainage Device

George Tanaka, MD

iStent Trabecular Microbypass Implantation Technique

iStent Trabecular Microbypass Implantation Technique

Ike K. Ahmed MD

Trabectome 180

Trabectome 180

Constance Okeke, MD, MSCE

New Directions for GT

New Directions for GT

Arsham Sheybani, MD, Iqbal Ike K. Ahmed, MD, FRCSC

Using Multiple Technologies to Reduce IOP and Drop Burden

I. Paul Singh, MD

I. Paul Singh, MD, demonstrates the use of multiple technologies to reduce a patient's IOP and glaucoma medication burden. He performs iTrack canaloplasty (Nova Eye Medical), iDose implantation (Glaukos), and Dextenza (dexamethasone ophthalmic insert 0.4 mg, Ocular Therapeutix) insertion.

Financial Disclosure: Consultant (Glaukos, Nova Eye Medical)

Posted: 2/17/2026

Keywords:

iTrack

•

iDose TR

•

Dextenza

Please log in to leave a comment.

More in Glaucoma

Academy IRIS® Registry Data Outcomes on Gel Stent Use

Academy IRIS® Registry Data Outcomes on Gel Stent Use

Arsham Sheybani, MD

A Monocular Patient With Significant OSD and Worsening Visual Acuity

A Monocular Patient With Significant OSD and Worsening Visual Acuity

John P. Berdahl, MD; Tanner J. Ferguson, MD; and Mitch Ibach, OD, FAAO

Excimer Laser Treatment for Open-Angle Glaucoma

Excimer Laser Treatment for Open-Angle Glaucoma

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; and Mark J. Gallardo, MD

Angle-Based MIGS for a Patient With Severe Glaucoma

Angle-Based MIGS for a Patient With Severe Glaucoma

John P. Berdahl, MD; Tanner J. Ferguson, MD; and Mitch Ibach, OD, FAAO